Oasmia Financial Statements From 2010 to 2026
| OASMY Stock | USD 0.01 0.00 0.00% |
Check Oasmia Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oasmia Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Oasmia financial statements analysis is a perfect complement when working with Oasmia Pharmaceutical Valuation or Volatility modules.
Oasmia |
Oasmia Pharmaceutical AB Company Return On Equity Analysis
Oasmia Pharmaceutical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Oasmia Pharmaceutical Return On Equity | -0.25 |
Most of Oasmia Pharmaceutical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oasmia Pharmaceutical AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Oasmia Pharmaceutical AB has a Return On Equity of -0.2542. This is 98.94% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 18.0% lower than that of the firm.
Oasmia Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Oasmia Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Oasmia Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oasmia Pharmaceutical competition to find correlations between indicators driving Oasmia Pharmaceutical's intrinsic value. More Info.Oasmia Pharmaceutical AB is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Oasmia Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Oasmia Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Oasmia Pharmaceutical Financial Statements
Oasmia Pharmaceutical investors use historical fundamental indicators, such as Oasmia Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Oasmia Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden. Vivesto Ab operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 17 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Additional Tools for Oasmia Pink Sheet Analysis
When running Oasmia Pharmaceutical's price analysis, check to measure Oasmia Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oasmia Pharmaceutical is operating at the current time. Most of Oasmia Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Oasmia Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oasmia Pharmaceutical's price. Additionally, you may evaluate how the addition of Oasmia Pharmaceutical to your portfolios can decrease your overall portfolio volatility.